Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

4.320 -0.140 (-3.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Sensus Healthcare, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Buys Back Shares
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Present at The Microcap Conference 2025
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Inc. (NASDAQ: SRTS) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
Sensus Healthcare Inc. (NASDAQ: SRTS) Near the Top of Equities by Percentage Gain on 1/23
Via Investor Brand Network
News headline image
Sensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025
From Sensus Healthcare
Via Business Wire
News headline image
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Via ACCESSWIRE
News headline image
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Sells SRT System to Providence Swedish Hospital
Continues customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancers 
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Participate in the 36th Annual Roth Conference
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital
Continues SRT-100+™ customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancers 
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare Announces New $3 Million Share Repurchase Program
From Sensus Healthcare, Inc.
Via GlobeNewswire
News headline image
Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
From Sensus Healthcare, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.